Foghorn Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- March 14, 2018
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $50,000,000
Company Info
- Founding Year
- 2016
- Founders
- Cigall Kadoch, Gerald Crabtree, Douglas Cole
- Company Description
- Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,
- Market
- Cancer and serious diseases
- Location
- Cambridge, MA, USA
- Coinvestors
- Flagship Pioneering